A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes

Abstract Background Both hypertension and dyslipidemia are considered as major modifiable risk factors of cardiovascular diseases (CVDs), and their prevalence in Egypt has increased in recent years. Evidence-based systematic evaluation of data on hypertension and dyslipidemia is critical for effecti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ashraf Reda, Hany Ragy, Kanwal Saeed, Mohammed Ashraf Alhussaini
Formato:	article
Lenguaje:	EN
Publicado:	SpringerOpen 2021
Materias:	Cardiovascular disease Dyslipidemia Egypt Hypertension Patient-centric Prevalence Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/005c06228777473b9e77204bf3864db7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:005c06228777473b9e77204bf3864db7
record_format	dspace
spelling	oai:doaj.org-article:005c06228777473b9e77204bf3864db72021-12-05T12:04:20ZA semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes10.1186/s42506-021-00096-92090-262Xhttps://doaj.org/article/005c06228777473b9e77204bf3864db72021-12-01T00:00:00Zhttps://doi.org/10.1186/s42506-021-00096-9https://doaj.org/toc/2090-262XAbstract Background Both hypertension and dyslipidemia are considered as major modifiable risk factors of cardiovascular diseases (CVDs), and their prevalence in Egypt has increased in recent years. Evidence-based systematic evaluation of data on hypertension and dyslipidemia is critical for effective patient-centric management to reduce the overall risk of CVDs in Egypt. This semi-systematic review aimed to quantify and identify data gaps in the prevalence and distribution of patient journey touchpoints including awareness, screening, diagnosis, treatment, adherence, and control of hypertension and dyslipidemia to provide the basis for research prioritization, practice guidance, and health care reforms in Egypt. Main body Structured search was conducted on MEDLINE and Embase to identify articles published in English between January 2010 and December 2019 that reported key patient journey touchpoints in hypertension and dyslipidemia management. Unstructured search was conducted on public or government websites with no date restriction. Data from all sources were extracted and presented descriptively. In total, 22 studies published between 1995 and 2020 on hypertension and dyslipidemia were included in the final analyses. The prevalence of hypertension in Egypt ranged from 12.1 to 59%. Studies reported awareness (37.5% and 43.9%), diagnosis (42% and 64.7%), treatment (24% and 54.1%), and adherence to antihypertensive medication (51.9%) to be low. Furthermore, the percentage of patients who had their blood pressure controlled ranged from 8 to 53.2%. The prevalence of dyslipidemia varied in the general population (range 19.2–36.8%) but was higher in patients with acute coronary syndrome (ACS) (50.9% and 52.5%) and coronary artery disease (58.7%). A national report indicated that 8.6% of the general population was screened for dyslipidemia; however, no data was available on the diagnosis and treatment rates. Among ACS patients, 73.9% were treated for dyslipidemia. Data indicated low levels of medication adherence (59%) among dyslipidemia patients, with overall low control rates ranging from 5.1 to 34.4% depending on CVD risk in populations including ACS patients. Conclusion Data on patient journey touchpoints of hypertension and dyslipidemia are limited in Egypt, indicating the need for more systematic and high-quality evidence-based studies covering different aspects of patient-centric management for better management of CVD and its risk factors.Ashraf RedaHany RagyKanwal SaeedMohammed Ashraf AlhussainiSpringerOpenarticleCardiovascular diseaseDyslipidemiaEgyptHypertensionPatient-centricPrevalenceArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENJournal of the Egyptian Public Health Association, Vol 96, Iss 1, Pp 1-14 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Cardiovascular disease Dyslipidemia Egypt Hypertension Patient-centric Prevalence Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270
spellingShingle	Cardiovascular disease Dyslipidemia Egypt Hypertension Patient-centric Prevalence Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Ashraf Reda Hany Ragy Kanwal Saeed Mohammed Ashraf Alhussaini A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
description	Abstract Background Both hypertension and dyslipidemia are considered as major modifiable risk factors of cardiovascular diseases (CVDs), and their prevalence in Egypt has increased in recent years. Evidence-based systematic evaluation of data on hypertension and dyslipidemia is critical for effective patient-centric management to reduce the overall risk of CVDs in Egypt. This semi-systematic review aimed to quantify and identify data gaps in the prevalence and distribution of patient journey touchpoints including awareness, screening, diagnosis, treatment, adherence, and control of hypertension and dyslipidemia to provide the basis for research prioritization, practice guidance, and health care reforms in Egypt. Main body Structured search was conducted on MEDLINE and Embase to identify articles published in English between January 2010 and December 2019 that reported key patient journey touchpoints in hypertension and dyslipidemia management. Unstructured search was conducted on public or government websites with no date restriction. Data from all sources were extracted and presented descriptively. In total, 22 studies published between 1995 and 2020 on hypertension and dyslipidemia were included in the final analyses. The prevalence of hypertension in Egypt ranged from 12.1 to 59%. Studies reported awareness (37.5% and 43.9%), diagnosis (42% and 64.7%), treatment (24% and 54.1%), and adherence to antihypertensive medication (51.9%) to be low. Furthermore, the percentage of patients who had their blood pressure controlled ranged from 8 to 53.2%. The prevalence of dyslipidemia varied in the general population (range 19.2–36.8%) but was higher in patients with acute coronary syndrome (ACS) (50.9% and 52.5%) and coronary artery disease (58.7%). A national report indicated that 8.6% of the general population was screened for dyslipidemia; however, no data was available on the diagnosis and treatment rates. Among ACS patients, 73.9% were treated for dyslipidemia. Data indicated low levels of medication adherence (59%) among dyslipidemia patients, with overall low control rates ranging from 5.1 to 34.4% depending on CVD risk in populations including ACS patients. Conclusion Data on patient journey touchpoints of hypertension and dyslipidemia are limited in Egypt, indicating the need for more systematic and high-quality evidence-based studies covering different aspects of patient-centric management for better management of CVD and its risk factors.
format	article
author	Ashraf Reda Hany Ragy Kanwal Saeed Mohammed Ashraf Alhussaini
author_facet	Ashraf Reda Hany Ragy Kanwal Saeed Mohammed Ashraf Alhussaini
author_sort	Ashraf Reda
title	A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
title_short	A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
title_full	A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
title_fullStr	A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
title_full_unstemmed	A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
title_sort	semi-systematic review on hypertension and dyslipidemia care in egypt—highlighting evidence gaps and recommendations for better patient outcomes
publisher	SpringerOpen
publishDate	2021
url	https://doaj.org/article/005c06228777473b9e77204bf3864db7
work_keys_str_mv	AT ashrafreda asemisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT hanyragy asemisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT kanwalsaeed asemisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT mohammedashrafalhussaini asemisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT ashrafreda semisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT hanyragy semisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT kanwalsaeed semisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes AT mohammedashrafalhussaini semisystematicreviewonhypertensionanddyslipidemiacareinegypthighlightingevidencegapsandrecommendationsforbetterpatientoutcomes
_version_	1718372233008644096

A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes

Ejemplares similares